| Hansoh Pharmaceutical Signs US$1.5 B AI Drug Discovery Collaboration with Atomwise |
Abstract
html
pdf
|
|
Anupama Sharma & Michelle Liu |
|
| Merck Signs Another Deal with 4D Pharma to Strengthen its Vaccine Portfolio |
Abstract
pdf
html
|
|
Sharath Chandra Nakka |
|
| Pfizer Licenses Akcea’s AKCEA-ANGPTL3-LRx |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Boehringer Ingelheim Targets KRAS Mutations with Lupin’s LNP3794 |
Abstract
html
pdf
|
|
Pratika Pahwa & Michelle Liu |
|
| Takeda Bolsters IBD Pipeline by Partnering with Prometheus Biosciences |
Abstract
pdf
html
|
|
Subham Nandi |
|
| Ipsen Boosts Rare Disease Portfolio with Blueprint’s BLU-782 |
Abstract
pdf
html
|
|
Pratika Pahwa |
|
| Sobi Acquires Dova in US$915 M Deal |
Abstract
pdf
html
|
|
Michelle Liu |
|
| UCB’s Bets on Complement Diseases with US$2.1 B Ra Pharma Acquisition |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Alexion Continues to Diversify its Portfolio with Achillion Acquisition |
Abstract
pdf
html
|
|
Michelle Liu |
|
